IOVANCE BIOTHERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Basic Shares Outstanding (Weighted Average) of 450.19 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 450.19K shares, a 34.58% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 418.51K shares, a 29.62% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 407.51K shares, a 33.61% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 364.04K shares, a 20.04% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 357.35K shares, a 23.27% increase from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 289.88K shares, a 23.28% increase from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 235.13K shares, a 47.64% increase from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 159.26K shares, a 3.82% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 450.19K shares 10-Q · filed 2026-08-06 | 434.44K shares 10-Q · filed 2026-08-06 | 425.40K shares derived: average of 3 quarters · filed 2026-08-06 | 410.06K shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 418.51K shares 10-Q · filed 2026-05-07 | 413.01K shares derived: average of 2 quarters · filed 2026-05-07 | 396.69K shares derived: average of 3 quarters · filed 2026-05-07 | 381.14K shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | 407.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 385.77K shares derived: average of 2 quarters · filed 2026-02-24 | 368.69K shares derived: average of 3 quarters · filed 2026-08-06 | 357.35K shares 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 364.04K shares 10-Q · filed 2025-11-06 | 349.27K shares derived: average of 2 quarters · filed 2026-08-06 | 340.62K shares 10-Q · filed 2025-11-06 | 331.60K shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | 334.51K shares 10-Q · filed 2026-08-06 | 328.72K shares 10-Q · filed 2026-08-06 | 320.79K shares derived: average of 3 quarters · filed 2026-08-06 | 316.41K shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | 322.87K shares 10-Q · filed 2026-05-07 | 313.93K shares derived: average of 2 quarters · filed 2026-05-07 | 310.38K shares derived: average of 3 quarters · filed 2026-05-07 | 303.99K shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 305.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 304.13K shares derived: average of 2 quarters · filed 2026-02-24 | 297.70K shares derived: average of 3 quarters · filed 2026-02-24 | 289.88K shares 10-K · filed 2026-02-24 | |||
| 2024-09-30 | 303.27K shares 10-Q · filed 2025-11-06 | 294.04K shares derived: average of 2 quarters · filed 2025-11-06 | 284.84K shares 10-Q · filed 2025-11-06 | 277.62K shares derived: average of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | 284.82K shares 10-Q · filed 2025-08-07 | 275.52K shares 10-Q · filed 2025-08-07 | 269.07K shares derived: average of 3 quarters · filed 2026-02-24 | 263.26K shares derived: average of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | 266.22K shares 10-Q · filed 2025-05-08 | 266.22M shares 10-Q · filed 2024-05-09 | 261.20K shares derived: average of 2 quarters · filed 2026-02-24 | 256.07K shares derived: average of 3 quarters · filed 2026-02-24 | 248.17K shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | 256.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 251.00K shares derived: average of 2 quarters · filed 2026-02-24 | 242.16K shares derived: average of 3 quarters · filed 2026-02-24 | 235.13K shares 10-K · filed 2026-02-24 | |||
| 2023-09-30 | 245.82K shares 10-Q · filed 2024-11-07 | 245.82M shares 10-Q · filed 2023-11-07 | 235.15K shares derived: average of 2 quarters · filed 2024-11-07 | 228.12K shares 10-Q · filed 2024-11-07 | 228.12M shares 10-Q · filed 2023-11-07 | -64.35M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | 224.48K shares 10-Q · filed 2024-08-08 | 224.48M shares 10-Q · filed 2023-08-08 | 219.12K shares 10-Q · filed 2024-08-08 | 219.12M shares 10-Q · filed 2023-08-08 | -85.89M shares derived: average of 3 quarters · filed 2025-02-27 | -24.96M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | 213.69M shares 10-Q · filed 2024-05-09 | -128.94M shares derived: average of 2 quarters · filed 2025-02-27 | -33.35M shares derived: average of 3 quarters · filed 2025-02-27 | 14.30M shares derived: average of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -471.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -156.88M shares derived: average of 2 quarters · filed 2025-02-27 | -52.16M shares derived: average of 3 quarters · filed 2025-02-27 | 159.26K shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 157.82M shares 10-Q · filed 2023-11-07 | 157.55M shares derived: average of 2 quarters · filed 2023-11-07 | 157.40M shares 10-Q · filed 2023-11-07 | 4.04M shares derived: average of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | 157.27M shares 10-Q · filed 2023-08-08 | 157.19M shares 10-Q · filed 2023-08-08 | -47.22M shares derived: average of 3 quarters · filed 2024-02-28 | 3.46M shares derived: average of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | 157.11M shares 10-Q · filed 2023-05-10 | 157.11K shares 10-Q · filed 2022-05-05 | -149.47M shares derived: average of 2 quarters · filed 2024-02-28 | -47.81M shares derived: average of 3 quarters · filed 2024-02-28 | 2.58M shares derived: average of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | -456.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -150.27M shares derived: average of 2 quarters · filed 2024-02-28 | -48.93M shares derived: average of 3 quarters · filed 2024-02-28 | 153.41K shares 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 155.51M shares 10-Q · filed 2022-11-03 | 155.51K shares 10-Q · filed 2021-11-04 | 154.63M shares derived: average of 2 quarters · filed 2022-11-03 | 152.22M shares 10-Q · filed 2022-11-03 | 152.22K shares 10-Q · filed 2021-11-04 | 77.39M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | 153.75M shares 10-Q · filed 2022-08-04 | 150.57M shares 10-Q · filed 2022-08-04 | 51.35M shares derived: average of 3 quarters · filed 2023-02-28 | 38.55M shares derived: average of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | 147.37K shares 10-Q · filed 2022-05-05 | 147.10K shares derived: average of 2 quarters · filed 2023-02-28 | 146.90K shares derived: average of 3 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | 146.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 146.66K shares derived: average of 2 quarters · filed 2023-02-28 | 138.30K shares 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | 146.49K shares 10-Q · filed 2021-11-04 | 135.46K shares 10-Q · filed 2021-11-04 | |||||
| 2019-12-31 | 124.34K shares 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |